Contact this trialFirst, we need to learn more about you.
Semaglutide D Dose 1 for Type 2 Diabetes
Recruiting3 awardsPhase 1
Overland Park, Kansas
This trial is investigating two different tablet versions of semaglutide to see which stays in the bloodstream longer. It will last around 29-31 weeks and will have three different groups receiving varying lengths of treatment.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.